[February 20, 2013]

Research and Markets: China Healthcare Company Analysis - China National Medicines Co., Ltd.

Research and Markets (http://www.researchandmarkets.com/research/bhdmtl/china_healthcare) has announced the addition of the "China Healthcare Company Analysis - China National Medicines Co., Ltd." company profile to their offering.

China National Medicines Corporation Ltd. (SinoPharm CNMC Ltd.) is one of the leading pharmaceutical companies in the Chinese drug distribution area. With SinoPharm as its key parent company, it had achieved revenues of RMB 7.0 billion in 2011. This report will provide you with more insightful information of SinoPharm CNMC Ltd., covering its history, business, evenues and costs, people, shareholders and subsidiaries, recent activities and future development.

Reasons of Buying

• More original information based on the Chinese language
• Detailed analysis of the company
• Constantly updated
• Strong after sale support to clients who have access to Shanghai-based experienced analysts for further questions

Who should Buy

• Decision makers who are looking for M&A opportunities in China
• Decision makers who are responsible for market intelligence in China
• Decision makers who are responsible for business development in China
• Investors
• Consultants

Key Topics Covered:

1. SinoPharm CNMC Ltd. Overview

2. Finance

2.1 Balance Sheet

2.2 Revenues

2.3 Costs

2.4 Profits

3. People

3.1 Board of Director

3.2 Management Team

3.3 Employee

4. Operation

4.1 Risk Analysis

4.2 Recent Activities

4.3 Future Development

5. Directory of SinoPharm CNMC Ltd.'s Related Companies

For more information visit http://www.researchandmarkets.com/research/bhdmtl/china_healthcare

[ Back To Technology News's Homepage ]